The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use
- PMID: 18462279
- DOI: 10.1111/j.1365-2753.2007.00921.x
The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use
Abstract
Objective: The Clinical Global Impression Scale (CGI) is established as a core metric in psychiatric research. This study aims to test the validity of CGI as a clinical outcome measure suitable for routine use in a private inpatient setting.
Methods: The CGI was added to a standard battery of routine outcome measures in a private psychiatric hospital. Data were collected on consecutive admissions over a period of 24 months, which included clinical diagnosis, demographics, service utilization and four routine measures (CGI, HoNOS, MHQ-14 and DASS-21) at both admission and discharge. Descriptive and comparative data analyses were performed.
Results: Of 786 admissions in total, there were 624 and 614 CGI-S ratings completed at the point of admission and discharge, respectively, and 610 completed CGI-I ratings. The admission and discharge CGI-S scores were correlated (r = 0.40), and the indirect improvement measures obtained from their differences were highly correlated with the direct CGI-I scores (r = 0.71). The CGI results reflected similar trends seen in the other three outcome measures.
Conclusions: The CGI is a valid clinical outcome measure suitable for routine use in an inpatient setting. It offers a number of advantages, including its established utility in psychiatric research, sensitivity to change, quick and simple administration, utility across diagnostic groupings, and reliability in the hands of skilled clinicians.
Similar articles
-
The concurrent validity and sensitivity of change of the German version of the health of the nation outcome scales in a psychiatric inpatient setting.Psychopathology. 2011;44(6):391-7. doi: 10.1159/000325172. Epub 2011 Sep 29. Psychopathology. 2011. PMID: 21968711
-
Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression.J Affect Disord. 2009 Jan;112(1-3):212-8. doi: 10.1016/j.jad.2008.03.024. Epub 2008 May 22. J Affect Disord. 2009. PMID: 18501434
-
The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure.Acta Neuropsychiatr. 2007 Oct;19(5):304-10. doi: 10.1111/j.1601-5215.2007.00217.x. Acta Neuropsychiatr. 2007. PMID: 26952943
-
[ROM in adult psychiatry: an evaluation of measurement instruments].Tijdschr Psychiatr. 2012;54(2):147-52. Tijdschr Psychiatr. 2012. PMID: 22331536 Review. Dutch.
-
A discussion on the role of clinimetrics and the misleading effects of psychometric theory.J Clin Epidemiol. 2005 Aug;58(8):753-6. doi: 10.1016/j.jclinepi.2004.12.006. J Clin Epidemiol. 2005. PMID: 16018909 Review.
Cited by
-
The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults.Eur Psychiatry. 2024 Sep 20;67(1):e53. doi: 10.1192/j.eurpsy.2024.1768. Eur Psychiatry. 2024. PMID: 39301594 Free PMC article.
-
Randomized controlled trial of the focus parent training for toddlers with autism: 1-year outcome.J Autism Dev Disord. 2010 Dec;40(12):1447-58. doi: 10.1007/s10803-010-1004-0. J Autism Dev Disord. 2010. PMID: 20440639 Free PMC article. Clinical Trial.
-
Assessing the severity of functional impairment of psychiatric disorders: equipercentile linking the mini-ICF-APP and CGI.Health Qual Life Outcomes. 2019 Nov 19;17(1):174. doi: 10.1186/s12955-019-1235-5. Health Qual Life Outcomes. 2019. PMID: 31744498 Free PMC article.
-
Prevention of Depression and Anxiety in Subclinical Adolescents: Effects of a Transdiagnostic Internet-Delivered CBT Program.Int J Environ Res Public Health. 2022 Apr 28;19(9):5365. doi: 10.3390/ijerph19095365. Int J Environ Res Public Health. 2022. PMID: 35564759 Free PMC article.
-
Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics.J Child Adolesc Psychopharmacol. 2013 Dec;23(10):665-75. doi: 10.1089/cap.2013.0007. Epub 2013 Nov 22. J Child Adolesc Psychopharmacol. 2013. PMID: 24266529 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical